Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.11851/10993
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Altan, Ş.A. | - |
dc.contributor.author | Kızıl, P.G. | - |
dc.contributor.author | Tarhan, N.Ç. | - |
dc.contributor.author | Adsan, O. | - |
dc.date.accessioned | 2024-01-21T09:24:30Z | - |
dc.date.available | 2024-01-21T09:24:30Z | - |
dc.date.issued | 2023 | - |
dc.identifier.issn | 2980-1478 | - |
dc.identifier.uri | https://doi.org/10.5152/tud.2023.23150 | - |
dc.identifier.uri | https://hdl.handle.net/20.500.11851/10993 | - |
dc.description.abstract | Objective: This article reports on the early results of a 1-year follow-up study investigating the efficacy of irreversible electroporation in the treatment of localized prostate cancer. Methods: The study included 18 out of 40 patients diagnosed with low-and intermedi-ate-risk prostate cancer who underwent irreversible electroporation. Treatment results were evaluated through confirmation biopsies, comparing prostate-specific antigen levels, international prostate symptom scoring, and international index of erectile dysfunction scores before irreversible electroporation and at the 12-month mark. Results: The mean age of the patients was 61.1 years (SD ±6.5). Out of the 18 patients, 16 were tumor free (88.8%), while 2 experienced recurrences, one within the treatment field and the other outside of it (P < .001). Irreversible electroporation significantly reduced mean prostate-specific antigen levels (6.73 ng/mL vs. 2.05 ng/mL, P < .001), indicating a 69.5% reduction within 12 months. Furthermore, there was a significant improvement in mean international prostate symptom scores at the 12-month follow-up (10.05 vs. 7.52, P = .003). The mean international index of erectile dysfunction scores before treatment was 19.17 (SD ±5.85), and after irreversible electroporation, it was 18.67 (SD ±6.34), with no statistically significant change (P = .065). Conclusion: The short-term oncological results of irreversible electroporation treatment are promising, particularly for patients in the low-and intermediate-risk groups. Additionally, irreversible electroporation does not negatively impact the international index of erectile dysfunction; however, it may lead to a decrease in international prostate symptom scores. © Author(s). | en_US |
dc.language.iso | en | en_US |
dc.publisher | AVES | en_US |
dc.relation.ispartof | Urology Research and Practice | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | focal ablation; follow-up; Irreversible electroporation; prostate cancer; treatment | en_US |
dc.title | One-Year Follow-Up Results of Transperineal Biopsy for Patients Undergoing Irreversible Electroporation Treatment in Localized Prostate Cancer | en_US |
dc.type | Article | en_US |
dc.department | TOBB ETÜ | en_US |
dc.identifier.volume | 49 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | 381 | en_US |
dc.identifier.endpage | 386 | en_US |
dc.identifier.wos | WOS:001135593000001 | - |
dc.identifier.scopus | 2-s2.0-85178931641 | - |
dc.institutionauthor | … | - |
dc.identifier.doi | 10.5152/tud.2023.23150 | - |
dc.authorscopusid | 57508068100 | - |
dc.authorscopusid | 57216852736 | - |
dc.authorscopusid | 6701662975 | - |
dc.authorscopusid | 6701657878 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopusquality | Q3 | - |
dc.identifier.trdizinid | 1265962 | - |
dc.identifier.wosquality | N/A | - |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairetype | Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection TR Dizin İndeksli Yayınlar / TR Dizin Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
1
checked on Jul 5, 2025
Page view(s)
58
checked on Jul 7, 2025
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.